Publications found:
73,128
Sort by:
The Oncolytic Virus Landscape 2017: an Analysis of Pipeline, Stakeholders, Deals, Industry Trends & Opportunities
US$ 2,400.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses was quite dormant in the first decade of the 2000s ... „The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities“ as of January 2017 brings you up-to-date regarding key players, key technologies, Oncolytic Virus projects ...
January 2017
225 pages
3D Imaging Market by Product Type (3D Cameras, Sonography, Smart Phones, and Others), by Image Sensor (Charged Coupled Device and Complementary Metal-Oxide Semiconductors), by End-User Industry (Entertainment, Healthcare, Architecture & Engineering, Industrial Applications, Security & Surveillance, and Others), by Application (3D Modelling, 3D Scanning, Layout & Animation, 3D Rendering, and Image Construction) - Global Opportunity Analysis and Industry Forecast, 2014-2022
US$ 5,540.00
... an upsurge in use of technology in products such as smartphones, tablets, televisions, computers, gaming, and others drive the 3D imaging market. Furthermore, 3D imaging software is extensively used in the ...
January 2017
144 pages
Epiomic Epidemiology Series: Chronic Hepatitis C Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... forecast snapshot. Chronic hepatitis C is most often associated with co-infections with other chronic viral ... information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
January 2017
60 pages
Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027
US$ 6,150.00
... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Muscular Dystrophies prevalent population. Identify sub-populations within Muscular Dystrophies which require treatment ...
January 2017
44 pages
Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027
US$ 6,150.00
... by a series of minor strokes. This report provides the current prevalent population for Vascular Dementia ... Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database ... from patient registries, clinical trials and epidemiology studies. All of the sources used ...
January 2017
50 pages
Epiomic Epidemiology Series: Multiple Sclerosis Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
January 2017
98 pages
Epiomic Epidemiology Series: Leukaemia Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...
January 2017
82 pages
Epiomic Epidemiology Series: Cholera Forecast for selected Asian Markets 2017-2027
US$ 2,900.00
... cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera ... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ...
January 2017
38 pages
Epiomic Epidemiology Series: Norovirus Forecast for selected Asian Markets 2017-2027
US$ 2,900.00
... of norovirus outbreaks. This report provides the current incident population for Norovirus across ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information form patient registries, clinical trials and epidemiology studies. All of the sources used to ...
January 2017
40 pages
Autism - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030
US$ 5,000.00
Thelansis Knowledge Partners 'Autism' - Market Outlook, Market Forecast and Competitive ... launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, ... Mortality 11 years of epidemiology and market projections Incidence/ Prevalence patient population Mortality, ...
December 2016
182 pages
Acne Vulgaris - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Acne Vulgaris' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
December 2016
152 pages
Acromegaly - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Acne Vulgaris' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
December 2016
193 pages
Acute Coronary Syndrome - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Acute Coronary Syndrome' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...
December 2016
161 pages
Allergic Conjunctivitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Allergic Conjunctivitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
December 2016
213 pages
Allergic Rhino-Conjunctivitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Allergic Rhino-Conjunctivitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
December 2016
187 pages
Alopecia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Alopecia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
December 2016
205 pages
Anaplastic Astrocytoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Anaplastic Astrocytoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
December 2016
147 pages
Angina (Angina Pectoris) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Angina (Angina Pectoris)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...
December 2016
165 pages
Ankylosing Spondylitis (Bekhterev'S Disease) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
... Ankylosing Spondylitis (Bekhterev's Disease)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease ... based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy, ...
December 2016
194 pages
Anterior Uveitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Anterior Uveitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
December 2016
192 pages
Aplastic Anemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Aplastic Anemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...
December 2016
202 pages
Binge (Eating) Disorders - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Binge (Eating) Disorders' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...
December 2016
176 pages
Aspergillosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Aspergillosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
December 2016
182 pages
Bacteremia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
Thelansis Knowledge Partners 'Bacteremia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...
December 2016
183 pages
Bacterial (Pyogenic) Meningitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030
US$ 6,550.00
... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low ... ; Incidence, Prevalence, Mortality 11 years of epidemiology and market projections Incidence/ Prevalence patient population Mortality, survival and diagnosed ...
December 2016
205 pages
Global Oncolytic Virus Therapy Market & Pipeline Outlook 2022
US$ 1,800.00
... clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical ...
December 2016
190 pages
Europe Mobile Patient Lifts Market by Manufacturers, Countries, Type and Application, Forecast to 2021
US$ 4,480.00
... Lifts Market Segment by Applications, can be divided into Hospital Nursing homes Old folks’ home Other There are 14 Chapters to deeply display the Europe Mobile Patient Lifts market. Chapter 1, to describe Mobile Patient Lifts Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Mobile Patient Lifts, with ...
December 2016
102 pages
US Healthcare IT Market Outlook 2022
US$ 1,500.00
... healthcare IT system in hospital is reviving the healthcare IT market while encouraging the investments from existing and new players. The latest report “US Healthcare IT Market Outlook ...
December 2016
130 pages
Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - Forecasts to 2021
US$ 3,390.00
... on the following pointers: Market Penetration: Comprehensive information on the solutions offered by top players in the clinical decision support systems market. The report analyzes the clinical decision support systems market, by component, delivery ... launches in the clinical decision support systems market Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the clinical decision support systems market across regions Market Diversification: Exh
December 2016
205 pages
Global Low Trauma/Skin Friendly Adhesives Market Outlook: 2014-2021
US$ 4,175.00
... opportunities in the global low trauma/skin friendly adhesives market? What are the burning issues of the global low trauma/skin friendly adhesives market? Who are the major players in the global low trauma/skin friendly adhesives market and ...
December 2016
148 pages
Non-Invasive Prenatal Testing Market Analysis by Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks), by Pregnancy RiskLevel (High & Average Risk, Low Risk), By Region (U.S., UK, Germany, Japan, China, Brazil)And Segment Forecasts, 2014 - 2025
US$ 5,950.00
The global non-invasive prenatal testing market is anticipated to reach USD 5.5 billion by 2025, according to a new report by Grand View Research, Inc. Evolution of prenatal testing in the form of noninvasive tests that ...
December 2016
100 pages
Competitor Analysis: CSF-1R Antagonists for Modulation of the Tumor Microenvironment
US$ 367.00
Competitor Analysis: CSF-1R Antagonists for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape of novel colony stimulating receptor 1 (CSF-1R) antagonists for modulation of the immunosuppressive tumor microenvironment as of December 2016. The Competitor Analysis includes antibody-based antagonists of CSF-1R as well as small molecule inhibitors of CSF-1R tyrosine ...
December 2016
19 pages
Competitor Analysis: CXCR4 Antagonists for Modulation of the Tumor Microenvironment
US$ 367.00
Competitor Analysis: CXCR4 Antagonists for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape of novel antagonists of the C-X-C chemokine receptor type 4 (CXCR4) and ... 2016. The Competitor Analysis includes antagonists of CXCR4 based on small molecules, peptides and antibodies as well as inhibitors of CXCL12, the ligand for CXCR4. Included are molecules ...
December 2016
20 pages
Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment
US$ 367.00
Competitor Analysis: IDO & TDO Inhibitors for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape of specific IDO and TDO inhibitors as well as dual ... comments with a hyperlink leading to the source of information. About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the ...
December 2016
38 pages
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology
US$ 2,310.00
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology This product consists of four reports in pdf ... Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β/R, CXCR4, CSF-1R, CD47-SIRPα, Adenosine, STING & Others Targets of Immunomodulators are inhibitory as well as stimulatory immune ...
December 2016
319 pages
Competitor Analysis: TGF-β Inhibitors for Modulation of the Tumor Microenvironment
US$ 367.00
Competitor Analysis: TGF-β Inhibitors for Modulation of the Tumor Microenvironment This industry report describes the competitive R&D landscape of specific TGF-beta inhibitors as well as TGF-beta receptor antagonists ... 2016. The Competitor Analysis includes antibody-based inhibitors of transforming growth factor beta (TGF-beta) or antagonists of TGF-beta receptors as well as small molecule inhibitors of TGF-beta receptor ...
December 2016
22 pages
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β/R, CXCR4, CSF-1R, CD47-SIRPα, Adenosine, STING & Others
US$ 1,283.00
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-β/R, CXCR4, CSF-1R, CD47-SIRPα, Adenosine, STING & Others This Competitive Intelligence report about Tumor Microenvironment Modulation via IDO, TGF ... active projects in research and development of modulators of the tumor microenvironment. In addition, the report lists company-specific R&D pipelines of Tumor Microenvironment Modulators. Competitor projects are listed in a tabular format ...
December 2016
117 pages
Report Package: Hot targets for empowered antibody and cell therapy technologies
US$ 2,090.00
... Package: Hot targets for empowered antibody and cell therapy technologies This package contains three reports analyzing BCMA, CD123 and CD22 as versatile and hot targets ... package of the three reports provides a 40% discount on the regular prices: B-Cell Maturation Antigen (BCMA): hot target for emerging treatment modalities CD123: a paradigmatic target ...
December 2016
202 pages
Breast Pumps Market by Technology (Battery Powered Breast Pumps, Manual Breast Pumps, and Electric Breast Pumps), Product Type (Closed System Breast Pumps and Open System Breast Pumps), and Application (Personal Use Pumps and Hospital/Healthcare Grade Pumps) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
US$ 5,540.00
... Market, By Technology Market, By Product Type Market, By Application United Arab Emirates Market, By Technology Market, By Product Type Market, By Application Rest of LAMEA Market, By Technology Market, By Product Type Market, By Application Key players operating in the breast pump market ...
December 2016
190 pages
Europe In Vitro Fertilization (IVF) Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022
US$ 3,962.00
... age and the success rate of getting pregnant via in vitro fertilization reduces with increase in age. Other factors that accelerate ... stress levels, change in lifestyle, and fertility-related diseases. In Europe, government regulations are favorable towards IVF treatments. The presence of regulatory and ...
December 2016
148 pages
Global Wound Care Market: Size, Trends & Forecasts (2016-2020)
US$ 800.00
... Report The report entitled “Global Wound Care Market: Size, Trends & Forecasts (2016-2020)” provides a detailed analysis of the global wound care market with analysis of market size by value, growth, segments, etc. The report also includes a detailed regional analysis of the wound care market in regions such ...
December 2016
61 pages
Epiomic Epidemiology Series: Adult Obstructive Sleep Apnoea Forecast in 8 Major Markets 2016-2026
US$ 6,150.00
Summary Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Adult Obstructive Sleep Apnoea in 8 Major Markets Adult obstructive sleep apnoea, otherwise known as Obstructive Sleep Apnea-Hypopnea (OSAH ... most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and ...
December 2016
44 pages
Epiomic Epidemiology Series: Acne Vulgaris Forecast in 15 Major Markets 2016-2026
US$ 6,150.00
Summary Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Acne Vulgaris in 15 Major Markets Acne, or Acne Vulgaris (AV), is a chronic inflammatory disease of the pilosebaceous unit. Although acne can develop at any ... on the impact from specific co-morbid conditions on Acne Vulgaris’s prevalent population. Identify sub-populations within Acne Vulgaris which require treatment. Gain an understanding of the ...
December 2016
72 pages
